Deciphering cholesterol treatment guidelines: a clinician's perspective.
作者信息
Ganda Om P
机构信息
Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA. 2015 Mar 10;313(10):1009-10. doi: 10.1001/jama.2015.216.
Abstract
摘要
相似文献
1
Deciphering cholesterol treatment guidelines: a clinician's perspective.解读胆固醇治疗指南：临床医生视角
JAMA. 2015 Mar 10;313(10):1009-10. doi: 10.1001/jama.2015.216.
2
New Cholesterol Guidelines Personalize Risk and Add Treatments.新的胆固醇指南实现风险个体化并增加治疗方法。
JAMA. 2019 Feb 26;321(8):731-732. doi: 10.1001/jama.2018.21019.
3
New guidelines in statin therapy.他汀类药物治疗的新指南。
Plast Surg Nurs. 2005 Apr-Jun;25(2):109-10. doi: 10.1097/00006527-200504000-00012.
4
Stricter cholesterol guidelines broaden indications for the 'statin' drugs.更严格的胆固醇指南扩大了“他汀类”药物的适用范围。
Medsurg Nurs. 2003 Feb;12(1):51-7.
5
Clinician Understanding of Cholesterol Treatment Guidelines.临床医生对胆固醇治疗指南的理解。
JAMA. 2015 Jun 16;313(23):2381-2. doi: 10.1001/jama.2015.5519.
6
Clinician Understanding of Cholesterol Treatment Guidelines--Reply.临床医生对胆固醇治疗指南的理解——回复
JAMA. 2015 Jun 16;313(23):2382. doi: 10.1001/jama.2015.5526.
7
8
The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.2013年美国心脏病学会/美国心脏协会血液胆固醇治疗指南：问题，问题，还是问题。
Circ Res. 2014 Feb 28;114(5):761-4. doi: 10.1161/CIRCRESAHA.114.303398.
9
IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?IMPROVE-IT的临床意义。“高强度降低胆固醇治疗”策略是否应取代“高强度他汀类药物治疗”？
Atherosclerosis. 2015 May;240(1):161-2. doi: 10.1016/j.atherosclerosis.2015.03.002. Epub 2015 Mar 10.
10
Achieving lipid goals. A study of outcomes in an NP Clinic.实现血脂目标。一项在护士执业诊所的结局研究。
Adv Nurse Pract. 2007 Jun;15(6):61-2, 64.
引用本文的文献
1
Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012.糖尿病合并高血压或高血脂患病率呈上升趋势：1999-2012 年 NHANES 数据分析。
Sci Rep. 2016 Nov 2;6:36093. doi: 10.1038/srep36093.
2
Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes.糖尿病脂质与高血压管理指南中的当前共识与争议
Curr Cardiol Rep. 2016 Nov;18(11):114. doi: 10.1007/s11886-016-0790-1.
3
Statin-induced diabetes: incidence, mechanisms, and implications.他汀类药物诱发的糖尿病：发病率、机制及影响
F1000Res. 2016 Jun 24;5. doi: 10.12688/f1000research.8629.1. eCollection 2016.
4
Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective.印度人群血脂异常管理的共识声明：一个不同的视角。
Indian Heart J. 2015 Mar-Apr;67(2):95-102. doi: 10.1016/j.ihj.2015.03.020. Epub 2015 Apr 30.
本文引用的文献
1
(8) Cardiovascular disease and risk management.（8）心血管疾病与风险管理。
Diabetes Care. 2015 Jan;38 Suppl:S49-57. doi: 10.2337/dc15-S011.
2
Prevention guidelines: bad process, bad outcome.预防指南：糟糕的流程，糟糕的结果。
JAMA Intern Med. 2014 Dec;174(12):1972-3. doi: 10.1001/jamainternmed.2014.3278.
3
National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.美国国家脂质协会血脂异常以患者为中心管理的建议：第1部分——执行摘要
J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15.
4
The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.2013年美国心脏病学会/美国心脏协会血液胆固醇治疗指南：问题，问题，还是问题。
Circ Res. 2014 Feb 28;114(5):761-4. doi: 10.1161/CIRCRESAHA.114.303398.
5
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.
Zotero 插件